References
- Lynette E., Jacobs P., Dowdle E. B. The secretion of plasminogen activators by human myeloid leukemic cells in vitro. Blood 1983; 61: 568–574
- Venuat A. M., Soria C., Soria J., Kriff P., Mirshani M., He L., Thomaidis A., Houllier A., Billard M., Bouch-Eix B. C. High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T-cell type origin. Cancer 1988; 62: 1952–1957
- Takahashi H., Tatewaki W., Wada K., Hanano M., Shibata A. Thrombin vs plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am. J. Hematol. 1990; 33: 90–95
- Takahashi H., Tatewaki W., Wada K., Niwano H., Shibata A. Fibrinolysis and fibrinogenolysis in patients with disseminated intravascular coagulation. Thrombos. Haemostas. 1990; 63: 340–344
- Avvisati G., Ten Cate J. W., Sturk A., Lampling R., Petti M. C., Mandelli F. Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia. Br. J. Haematol. 1988; 70: 43–48
- Kahle L. H., Avvisati G., Lampling R. J., Moretti T., Mandelli F., Ten Cate J. W. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia. Scand. J. Clin. Lab. Invest. 1985; 45(Suppl. 178)75–80
- Darras V., Thienpont M., Stump D. C., Collen D. Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies. Thrombos. Haemostas. 1986; 56: 411–414
- Grondahl-Hansen J., Agerlin N., Munkholm-Larsen P., Bach F., Nielsen L. S., Dowbemowsky P., Don K. Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer. J. Lab. Clin. Med. 1988; Ill: 42–51
- Mimuro J., Koike Y., Sumi Y., Aoki N. Monoclonal antibodies to discrete regions in α2-plasmin inhibitor. Blood 1987; 69: 446–453
- Bennet B., Booth A., Croll A., Dowson B. The bleeding disorder in acute promyelocytic leukaemia: fibrinolysis due to u-PA rather than defibrination. Br. J. Haematol. 1989; 71: 511–517
- Asakura H. Activation of intravascular coagulation and fibrinolysis in cases of APL. Jpn. J. Clin. Pathol. 1989; 81: 224–228
- Dombret H., Scrobohaci M. L., Ghorra P., Daniel M. T., Castaigne S., Degos L. Coagulation disorders associated with acute promyelocytic leukemia: Corrective effect of all-trans retinoic acid treatment. Leukemia 1993; 7: 2–9